🔎 Trials Near Me

Beranda › Glaucoma Sudut Terbuka › Pennsylvania

Uji klinis Glaucoma Sudut Terbuka di Pennsylvania

6 studi untuk Glaucoma Sudut Terbuka mencari peserta di lokasi di Pennsylvania.

Kota di Pennsylvania

Teks studi resmi (Bahasa Inggris)

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

  • Ophthalmic Partners of PA /ID# 276059, Bala-Cynwyd
  • Wills Eye Hospital /ID# 268569, Philadelphia
Menerima pesertaFase 3
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06822738

Hydrus® Microstent New Enrollment Post-Approval Study

  • Scott & Christie and Associates, PC, Cranberry Township
Menerima peserta
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04553523

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

  • Wills Eye Glaucoma Service, Philadelphia
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT03675412

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

  • Scheie Eye Institute, Philadelphia
  • Wills Eye Hospital, Philadelphia
Menerima peserta
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT07220876

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

  • Wills Eye Hosital Glaucoma Dept., Philadelphia
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT07228221

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

  • Shafer Vision Institute, Plymouth Meeting
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2025 · NCT07076303

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.